These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21264536)

  • 1. The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer.
    Huang KJ; Sui LH
    Med Oncol; 2012 Mar; 29(1):318-23. PubMed ID: 21264536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. URG4 upregulation is associated with tumor growth and poor survival in epithelial ovarian cancer.
    Li W; Zhou N
    Arch Gynecol Obstet; 2012 Jul; 286(1):209-15. PubMed ID: 22395861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
    Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
    Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of MMP-2, -7, -9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer.
    Brun JL; Cortez A; Lesieur B; Uzan S; Rouzier R; Daraï E
    Oncol Rep; 2012 Apr; 27(4):1049-57. PubMed ID: 22200690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer.
    Wang M; He Y; Shi L; Shi C
    Eur J Gynaecol Oncol; 2011; 32(2):171-7. PubMed ID: 21614907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer.
    Gao H; Lan X; Li S; Xue Y
    Tumour Biol; 2017 May; 39(5):1010428317698368. PubMed ID: 28459196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-expression of semaphorin4D, hypoxia-inducible factor-1α and vascular endothelial growth factor is related to poor prognosis in ovarian epithelial cancer.
    Chen Y; Zhang L; Pan Y; Ren X; Hao Q
    Int J Mol Sci; 2012 Oct; 13(10):13264-74. PubMed ID: 23202951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression levels of PTEN, HIF-1α, and VEGF as prognostic factors in ovarian cancer.
    Shen W; Li HL; Liu L; Cheng JX
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2596-2603. PubMed ID: 28678326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer.
    Yang S; Li H; Liu Y; Ning X; Meng F; Xiao M; Wang D; Lou G; Zhang Y
    Med Oncol; 2013 Mar; 30(1):324. PubMed ID: 23254963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer.
    Bodnar L; Stanczak A; Cierniak S; Smoter M; Cichowicz M; Kozlowski W; Szczylik C; Wieczorek M; Lamparska-Przybysz M
    J Ovarian Res; 2014 Feb; 7():16. PubMed ID: 24499657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and clinical significance of cortactin protein in ovarian neoplasms.
    Li A; Zhang L; Zhang X; Jin W; Ren Y
    Clin Transl Oncol; 2016 Feb; 18(2):220-7. PubMed ID: 26243395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear β-catenin positivity as a predictive marker of long-term survival in advanced epithelial ovarian cancer.
    Nagy B; Tóth L; Molnár P; Méhes G; Thurzó L; Póka R; Hernádi Z
    Pathol Res Pract; 2017 Aug; 213(8):915-921. PubMed ID: 28651933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant Beclin 1 expression is closely linked to carcinogenesis, differentiation, progression, and prognosis of ovarian epithelial carcinoma.
    Zhao Y; Chen S; Gou WF; Xiao LJ; Takano Y; Zheng HC
    Tumour Biol; 2014 Mar; 35(3):1955-64. PubMed ID: 24132590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
    Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
    Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sprouty 2 protein, but not Sprouty 4, is an independent prognostic biomarker for human epithelial ovarian cancer.
    Masoumi-Moghaddam S; Amini A; Wei AQ; Robertson G; Morris DL
    Int J Cancer; 2015 Aug; 137(3):560-70. PubMed ID: 25630587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer.
    Ma M; Yu N
    Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.
    Li T; Xue H; Guo Y; Guo K
    Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer.
    Hou T; Yang C; Tong C; Zhang H; Xiao J; Li J
    Int J Clin Exp Pathol; 2014; 7(1):280-7. PubMed ID: 24427349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of metastasis-related genes in human epithelial ovarian tumors.
    Herrera CA; Xu L; Bucana CD; Silva el VG; Hess KR; Gershenson DM; Fidler IJ
    Int J Oncol; 2002 Jan; 20(1):5-13. PubMed ID: 11743636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of TBC1D16 Is Associated with Favorable Prognosis of Epithelial Ovarian Cancer.
    Yang Z; Shen H; He W; Ouyang L; Guo Y; Qian F; Xu B; Xie D; Yang G
    Tohoku J Exp Med; 2018 Jul; 245(3):141-148. PubMed ID: 29962380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.